{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T18:13:39Z","timestamp":1794075219334,"version":"4.8.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple system atrophy (MSA) is a rare, adult-onset, progressive neurodegenerative disorder with major diagnostic challenges. Aiming for a better diagnostic accuracy particularly at early disease stages, novel Movement Disorder Society criteria for the diagnosis of MSA (MDS MSA criteria) have been recently developed. They introduce a neuropathologically established MSA category and three levels of clinical diagnostic certainty including clinically established MSA, clinically probable MSA, and the research category of possible prodromal MSA. The diagnosis of clinically established and clinically probable MSA is based on the presence of cardiovascular or urological autonomic failure, parkinsonism (poorly L-Dopa-responsive for the diagnosis of clinically established MSA), and cerebellar syndrome. These core clinical features need to be associated with supportive motor and non-motor features (MSA red flags) and absence of any exclusion criteria. Characteristic brain MRI markers are required for a diagnosis of clinically established MSA. A research category of possible prodromal MSA is devised to capture patients manifesting with autonomic failure or REM sleep behavior disorder and only mild motor signs at the earliest disease stage. There is a number of promising laboratory markers for MSA that may help increase the overall clinical diagnostic accuracy. In this review, we will discuss the core and supportive clinical features for a diagnosis of MSA in light of the new MDS MSA criteria, which laboratory tools may assist in the clinical diagnosis and which major differential diagnostic challenges should be borne in mind.<\/jats:p>","DOI":"10.1007\/s12311-022-01453-w","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T15:02:26Z","timestamp":1660921346000},"page":"825-839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["A Review on the Clinical Diagnosis of Multiple System Atrophy"],"prefix":"10.1007","volume":"22","author":[{"given":"Iva","family":"Stankovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2854-4179","authenticated-orcid":false,"given":"Alessandra","family":"Fanciulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Sidoroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor K.","family":"Wenning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"1453_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1056\/NEJMra1311488","volume":"372","author":"A Fanciulli","year":"2015","unstructured":"Fanciulli A, Wenning GK. Multiple-system atrophy. N Engl J Med. 2015;372:249\u201363. https:\/\/doi.org\/10.1056\/NEJMra1311488.","journal-title":"N Engl J Med"},{"key":"1453_CR2","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/brain\/awf117","volume":"125","author":"H Watanabe","year":"2002","unstructured":"Watanabe H, Saito Y, Terao S, Ando T, Kachi T, Mukai E, Aiba I, Abe Y, Tamakoshi A, Doyu M, Hirayama M, Sobue G. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain. 2002;125:1070\u201383. https:\/\/doi.org\/10.1093\/brain\/awf117.","journal-title":"Brain"},{"key":"1453_CR3","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/mds.23185","volume":"25","author":"JH Seo","year":"2010","unstructured":"Seo JH, Yong SW, Song SK, Lee JE, Sohn YH, Lee PH. A case-control study of multiple system atrophy in Korean patients. Mov Disord. 2010;25:1953\u20139. https:\/\/doi.org\/10.1002\/mds.23185.","journal-title":"Mov Disord"},{"key":"1453_CR4","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1002\/mds.28177","volume":"35","author":"YH Lee","year":"2020","unstructured":"Lee YH, Ando T, Lee JJ, Baek MS, Lyoo CH, Kim SJ, Kim M, Cho JW, Sohn YH, Katsuno M, Watanabe H, Yoshida M, Lee PH. Later-onset multiple system atrophy: a multicenter Asian study. Mov Disord. 2020;35:1692\u20133. https:\/\/doi.org\/10.1002\/mds.28177.","journal-title":"Mov Disord"},{"key":"1453_CR5","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/cpt.2082","volume":"109","author":"J Jung Lee","year":"2021","unstructured":"Jung Lee J, Han Yoon J, Jin Kim S, Soo Yoo H, Jong Chung S, Hyun Lee Y, Yun Kang S, Shin HW, Keun Song S, Yong Hong J, Sunwoo M, Eun Lee J, Sam Baik J, Sohn YH, Hyu LP. Inosine 5\u2032-monophosphate to raise serum uric acid level in multiple system atrophy (IMPROVE-MSA study). Clin Pharmacol Ther. 2021;109:1274\u201381. https:\/\/doi.org\/10.1002\/cpt.2082.","journal-title":"Clin Pharmacol Ther"},{"key":"1453_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.parkreldis.2018.04.016","volume":"54","author":"B Cao","year":"2018","unstructured":"Cao B, Zhang L, Zou Y, Wei Q, Ou R, Chen Y, Shang HF. Survival analysis and prognostic nomogram model for multiple system atrophy. Parkinsonism Relat Disord. 2018;54:68\u201373. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.04.016.","journal-title":"Parkinsonism Relat Disord"},{"key":"1453_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1135","volume":"8","author":"JJ Du","year":"2018","unstructured":"Du JJ, Wang T, Huang P, Cui S, Gao C, Lin Y, Fu R, Zhou H, Chen S. Clinical characteristics and quality of life in Chinese patients with multiple system atrophy. Brain and behavior. 2018;8: e01135. https:\/\/doi.org\/10.1002\/brb3.1135.","journal-title":"Brain and behavior"},{"key":"1453_CR8","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/mds.23580","volume":"26","author":"HJ Kim","year":"2011","unstructured":"Kim HJ, Jeon BS, Lee JY, Yun JY. Survival of Korean patients with multiple system atrophy. Mov Disord. 2011;26:909\u201312. https:\/\/doi.org\/10.1002\/mds.23580.","journal-title":"Mov Disord"},{"key":"1453_CR9","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1002\/mds.23192","volume":"25","author":"M Kollensperger","year":"2010","unstructured":"Kollensperger M, Geser F, Ndayisaba JP, Boesch S, Seppi K, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Klockgether T, Yekhlef F, Tison F, Daniels C, Deuschl G, Coelho M, Sampaio C, Bozi M, Quinn N, Schrag A, Mathias CJ, Fowler C, Nilsson CF, Widner H, Schimke N, Oertel W, Del Sorbo F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Colosimo C, Meco G, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Rascol O, Kamm C, Gasser T, Siebert U, Poewe W, Wenning GK. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord. 2010;25:2604\u201312. https:\/\/doi.org\/10.1002\/mds.23192.","journal-title":"Mov Disord"},{"key":"1453_CR10","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s00702-005-0381-6","volume":"112","author":"S Gilman","year":"2005","unstructured":"Gilman S, May SJ, Shults CW, Tanner CM, Kukull W, Lee VM, Masliah E, Low P, Sandroni P, Trojanowski JQ, Ozelius L, Foroud T. The North American Multiple System Atrophy Study Group. J Neural Transm. 2005;112:1687\u201394. https:\/\/doi.org\/10.1007\/s00702-005-0381-6.","journal-title":"J Neural Transm"},{"key":"1453_CR11","doi-asserted-by":"publisher","unstructured":"Regragui W, Lachhab L, Razine R, Benjelloun H, Ait Benhaddou EH, Benomar A and Yahyaoui M. Profile of multiple system atrophy in Moroccan patients attending a movement disorders outpatient clinic in Rabat university hospital. Rev Neurol (Paris) 2012. S0035\u20133787(12)00824\u20137 [pii]https:\/\/doi.org\/10.1016\/j.neurol.2012.04.006.","DOI":"10.1016\/j.neurol.2012.04.006"},{"key":"1453_CR12","doi-asserted-by":"publisher","unstructured":"Gatto E, Rodriguez-Violante M, Cosentino C, Chana-Cuevas P, Miranda M, Gallin E, Etcheverry JL, Nunez Y, Parisi V, Persi G, Vecchi C, Sanguinetti A, Alleva A, Aparcana J, Torres L and Litvan I. Pan-American Consortium of Multiple System Atrophy (PANMSA). A Pan-American multicentre cohort study of multiple system atrophy. Journal of Parkinson\u2019s disease 2014: 4:693\u20138. https:\/\/doi.org\/10.3233\/JPD-140434.","DOI":"10.3233\/JPD-140434"},{"key":"1453_CR13","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1093\/brain\/awz189","volume":"142","author":"Y Miki","year":"2019","unstructured":"Miki Y, Foti SC, Asi YT, Tsushima E, Quinn N, Ling H, Holton JL. Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. Brain. 2019;142:2813\u201327. https:\/\/doi.org\/10.1093\/brain\/awz189.","journal-title":"Brain"},{"key":"1453_CR14","doi-asserted-by":"publisher","unstructured":"Quinn N. Multiple system atrophy--the nature of the beast. J Neurol Neurosurg Psychiatry 1989: Suppl:78\u201389. https:\/\/doi.org\/10.1136\/jnnp.52.suppl.78.","DOI":"10.1136\/jnnp.52.suppl.78"},{"key":"1453_CR15","doi-asserted-by":"publisher","unstructured":"Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I and Wenning G. Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res.\u00a01998;8:359\u201362. https:\/\/doi.org\/10.1007\/BF02309628.","DOI":"10.1007\/BF02309628"},{"key":"1453_CR16","doi-asserted-by":"publisher","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K and Vidailhet M. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008: 71:670\u20136. 71\/9\/670 [pii].\u00a0https:\/\/doi.org\/10.1212\/01.wnl.0000324625.00404.15.","DOI":"10.1212\/01.wnl.0000324625.00404.15"},{"key":"1453_CR17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/WNL.0000000000001807","volume":"85","author":"S Koga","year":"2015","unstructured":"Koga S, Aoki N, Uitti RJ, van Gerpen JA, Cheshire WP, Josephs KA, Wszolek ZK, Langston JW, Dickson DW. When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology. 2015;85:404\u201312. https:\/\/doi.org\/10.1212\/WNL.0000000000001807.","journal-title":"Neurology"},{"key":"1453_CR18","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1002\/mds.22826","volume":"24","author":"Y Osaki","year":"2009","unstructured":"Osaki Y, Ben-Shlomo Y, Lees AJ, Wenning GK, Quinn NP. A validation exercise on the new consensus criteria for multiple system atrophy. Mov Disord. 2009;24:2272\u20136. https:\/\/doi.org\/10.1002\/mds.22826.","journal-title":"Mov Disord"},{"key":"1453_CR19","doi-asserted-by":"publisher","unstructured":"Stankovic I, Quinn N, Vignatelli L, Antonini A, Berg D, Coon E, Cortelli P, Fanciulli A, Ferreira JJ, Freeman R, Halliday G, Hoglinger GU, Iodice V, Kaufmann H, Klockgether T, Kostic V, Krismer F, Lang A, Levin J, Low P, Mathias C, Meissner WG, Kaufmann LN, Palma JA, Panicker JN, Pellecchia MT, Sakakibara R, Schmahmann J, Scholz SW, Singer W, Stamelou M, Tolosa E, Tsuji S, Seppi K, Poewe W, Wenning GK and Movement Disorder Society Multiple System Atrophy Study G. A critique of the second consensus criteria for multiple system atrophy. Mov Disord 2019: 34:975\u201384. https:\/\/doi.org\/10.1002\/mds.27701","DOI":"10.1002\/mds.27701"},{"key":"1453_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29005","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K, Palma JA, Meissner WG, Krismer F, Berg D, Cortelli P, Freeman R, Halliday G, Hoglinger G, Lang A, Ling H, Litvan I, Low P, Miki Y, Panicker J, Pellecchia MT, Quinn N, Sakakibara R, Stamelou M, Tolosa E, Tsuji S, Warner T, Poewe W, Kaufmann H. The Movement Disorder Society criteria for the diagnosis of multiple system atrophy. Mov Disord. 2022. https:\/\/doi.org\/10.1002\/mds.29005.","journal-title":"Mov Disord"},{"key":"1453_CR21","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1474-4422(21)00292-1","volume":"20","author":"A Fanciulli","year":"2021","unstructured":"Fanciulli A, Wenning GK. Autonomic failure: a neglected presentation of Parkinson\u2019s disease. Lancet Neurol. 2021;20:781\u20132. https:\/\/doi.org\/10.1016\/S1474-4422(21)00292-1.","journal-title":"Lancet Neurol"},{"key":"1453_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ana.24877","volume":"81","author":"H Kaufmann","year":"2017","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, Low PA, Singer W, Goldstein DS, Peltier AC, Shibao CA, Gibbons CH, Freeman R, Robertson D. Natural history of pure autonomic failure: a United States prospective cohort. Ann Neurol. 2017;81:287\u201397. https:\/\/doi.org\/10.1002\/ana.24877.","journal-title":"Ann Neurol"},{"key":"1453_CR23","doi-asserted-by":"publisher","first-page":"e1245","DOI":"10.1212\/WNL.0000000000006243","volume":"91","author":"G Giannini","year":"2018","unstructured":"Giannini G, Calandra-Buonaura G, Asioli GM, Cecere A, Barletta G, Mignani F, Ratti S, Guaraldi P, Provini F, Cortelli P. The natural history of idiopathic autonomic failure: the IAF-BO cohort study. Neurology. 2018;91:e1245\u201354. https:\/\/doi.org\/10.1212\/WNL.0000000000006243.","journal-title":"Neurology"},{"key":"1453_CR24","doi-asserted-by":"publisher","first-page":"e889","DOI":"10.1212\/WNL.0000000000010002","volume":"95","author":"EA Coon","year":"2020","unstructured":"Coon EA, Mandrekar JN, Berini SE, Benarroch EE, Sandroni P, Low PA, Singer W. Predicting phenoconversion in pure autonomic failure. Neurology. 2020;95:e889\u201397. https:\/\/doi.org\/10.1212\/WNL.0000000000010002.","journal-title":"Neurology"},{"key":"1453_CR25","doi-asserted-by":"publisher","unstructured":"Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C and Leigh PN. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 2009: 132:156\u201371. awn291 [pii]https:\/\/doi.org\/10.1093\/brain\/awn291.","DOI":"10.1093\/brain\/awn291"},{"key":"1453_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s100720100005","volume":"22","author":"D Testa","year":"2001","unstructured":"Testa D, Monza D, Ferrarini M, Soliveri P, Girotti F, Filippini G. Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy. Neurol Sci. 2001;22:247\u201351. https:\/\/doi.org\/10.1007\/s100720100005.","journal-title":"Neurol Sci"},{"key":"1453_CR27","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S1474-4422(15)00070-8","volume":"14","author":"JN Panicker","year":"2015","unstructured":"Panicker JN, Fowler CJ, Kessler TM. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol. 2015;14:720\u201332. https:\/\/doi.org\/10.1016\/S1474-4422(15)00070-8.","journal-title":"Lancet Neurol"},{"key":"1453_CR28","doi-asserted-by":"publisher","unstructured":"Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S, Kollensperger M, Goebel G, Pfeiffer KP, Barone P, Pellecchia MT, Quinn NP, Koukouni V, Fowler CJ, Schrag A, Mathias CJ, Giladi N, Gurevich T, Dupont E, Ostergaard K, Nilsson CF, Widner H, Oertel W, Eggert KM, Albanese A, Del Sorbo F, Tolosa E, Cardozo A, Deuschl G, Hellriegel H, Klockgether T, Dodel R, Sampaio C, Coelho M, Djaldetti R, Melamed E, Gasser T, Kamm C, Meco G, Colosimo C, Rascol O, Meissner WG, Tison F and Poewe W. The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 2013. S1474\u20134422(12)70327\u20137 [pii].\u00a0https:\/\/doi.org\/10.1016\/S1474-4422(12)70327-7.","DOI":"10.1016\/S1474-4422(12)70327-7"},{"key":"1453_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00058-7","author":"PA Low","year":"2015","unstructured":"Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, Tanner CM, Gilman S, Marshall FJ, Wooten F, Racette B, Chelimsky T, Singer W, Sletten DM, Sandroni P, Mandrekar J. Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol. 2015. https:\/\/doi.org\/10.1016\/S1474-4422(15)00058-7.","journal-title":"Lancet Neurol"},{"key":"1453_CR30","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1002\/mds.20586","volume":"20","author":"K Hahn","year":"2005","unstructured":"Hahn K, Ebersbach G. Sonographic assessment of urinary retention in multiple system atrophy and idiopathic Parkinson\u2019s disease. Mov Disord. 2005;20:1499\u2013502. https:\/\/doi.org\/10.1002\/mds.20586.","journal-title":"Mov Disord"},{"key":"1453_CR31","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/mds.10384","volume":"18","author":"WH Oertel","year":"2003","unstructured":"Oertel WH, Wachter T, Quinn NP, Ulm G, Brandstadter D. Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type. Mov Disord. 2003;18:430\u20132. https:\/\/doi.org\/10.1002\/mds.10384.","journal-title":"Mov Disord"},{"key":"1453_CR32","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s10286-021-00825-2","volume":"31","author":"C Raccagni","year":"2021","unstructured":"Raccagni C, Indelicato E, Sidoroff V, Daniaux M, Bader A, Toth B, Jelisejevas LA, Hochleitner M, Fanciulli A, Leys F, Eschlboeck S, Kaindlstorfer C, Boesch S, Wenning GK. Female sexual dysfunction in multiple system atrophy: a prospective cohort study. Clin Auton Res. 2021;31:713\u20137. https:\/\/doi.org\/10.1007\/s10286-021-00825-2.","journal-title":"Clin Auton Res"},{"key":"1453_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/mds.870120203","volume":"12","author":"GK Wenning","year":"1997","unstructured":"Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord. 1997;12:133\u201347. https:\/\/doi.org\/10.1002\/mds.870120203.","journal-title":"Mov Disord"},{"key":"1453_CR34","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00415-019-09597-2","volume":"267","author":"JN Panicker","year":"2020","unstructured":"Panicker JN, Simeoni S, Miki Y, Batla A, Iodice V, Holton JL, Sakakibara R, Warner TT. Early presentation of urinary retention in multiple system atrophy: can the disease begin in the sacral spinal cord? J Neurol. 2020;267:659\u201364. https:\/\/doi.org\/10.1007\/s00415-019-09597-2.","journal-title":"J Neurol"},{"key":"1453_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","volume":"21","author":"R Freeman","year":"2011","unstructured":"Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA, Mathias C, Raj SR, Robertson D, Sandroni P, Schatz I, Schondorff R, Stewart JM, van Dijk JG. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69\u201372. https:\/\/doi.org\/10.1007\/s10286-011-0119-5.","journal-title":"Clin Auton Res"},{"key":"1453_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1056\/NEJMra1509723","volume":"382","author":"H Kaufmann","year":"2020","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Palma JA. Baroreflex dysfunction. N Engl J Med. 2020;382:163\u201378. https:\/\/doi.org\/10.1056\/NEJMra1509723.","journal-title":"N Engl J Med"},{"key":"1453_CR37","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.25170","volume":"83","author":"L Norcliffe-Kaufmann","year":"2018","unstructured":"Norcliffe-Kaufmann L, Kaufmann H, Palma JA, Shibao CA, Biaggioni I, Peltier AC, Singer W, Low PA, Goldstein DS, Gibbons CH, Freeman R, Robertson D. Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Ann Neurol. 2018;83:522\u201331. https:\/\/doi.org\/10.1002\/ana.25170.","journal-title":"Ann Neurol"},{"key":"1453_CR38","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ana.25834","volume":"88","author":"A Fanciulli","year":"2020","unstructured":"Fanciulli A, Kerer K, Leys F, Seppi K, Kaufmann H, Norcliffe-Kaufmann L, Wenning GK. Validation of the neurogenic orthostatic hypotension ratio with active standing. Ann Neurol. 2020;88:643\u20135. https:\/\/doi.org\/10.1002\/ana.25834.","journal-title":"Ann Neurol"},{"key":"1453_CR39","doi-asserted-by":"publisher","unstructured":"Poewe W. PB, N. Gliadi, S. Gilman, P.A. Low, C. Sampaio, K. Seppi, G.K. Wenning, For the Rasagiline-for-MSA Investigators. Abstracts of the Sixteenth International Congress of Parkinson\u2019s Disease and Movement Disorders. June 17\u201321, 2012. Dublin, Ireland. Mov Disord 2012: 27 Suppl 1:S390. https:\/\/doi.org\/10.1002\/mds.25051.","DOI":"10.1002\/mds.25051"},{"key":"1453_CR40","doi-asserted-by":"publisher","unstructured":"Ha AD, Brown CH, York MK and Jankovic J. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson\u2019s disease and atypical parkinsonism. Parkinsonism Relat Disord 2011: 17:625\u20138. S1353\u20138020(11)00152\u20130 [pii].\u00a0https:\/\/doi.org\/10.1016\/j.parkreldis.2011.05.020","DOI":"10.1016\/j.parkreldis.2011.05.020"},{"key":"1453_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12311-011-0299-5","volume":"11","author":"GK Wenning","year":"2012","unstructured":"Wenning GK, Granata R, Krismer F, Durr S, Seppi K, Poewe W, Bleasdale-Barr K, Mathias CJ. Orthostatic hypotension is differentially associated with the cerebellar versus the parkinsonian variant of multiple system atrophy: a comparative study. Cerebellum. 2012;11:223\u20136. https:\/\/doi.org\/10.1007\/s12311-011-0299-5.","journal-title":"Cerebellum"},{"key":"1453_CR42","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1002\/mds.27917","volume":"34","author":"A Fanciulli","year":"2019","unstructured":"Fanciulli A, Goebel G, Lazzeri G, Granata R, Kiss G, Strano S, Colosimo C, Pontieri FE, Kaufmann H, Seppi K, Poewe W, Wenning GK. Urinary retention discriminates multiple system atrophy from Parkinson\u2019s disease. Mov Disord. 2019;34:1926\u20138. https:\/\/doi.org\/10.1002\/mds.27917.","journal-title":"Mov Disord"},{"key":"1453_CR43","doi-asserted-by":"publisher","unstructured":"Pavy-Le Traon A, Piedvache A, Perez-Lloret S, Calandra-Buonaura G, Cochen-De Cock V, Colosimo C, Cortelli P, Debs R, Duerr S, Fanciulli A, Foubert-Samier A, Gerdelat A, Gurevich T, Krismer F, Poewe W, Tison F, Tranchant C, Wenning G, Rascol O, Meissner WG and European MSASG. New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study. J Neurol Neurosurg Psychiatry 2015. https:\/\/doi.org\/10.1136\/jnnp-2014-309999.","DOI":"10.1136\/jnnp-2014-309999"},{"key":"1453_CR44","doi-asserted-by":"publisher","unstructured":"Frongillo D, Stocchi F, Buccolini P, Stecconi P, Viselli F, Ruggieri S and Cannata D. Ambulatory blood pressure monitoring and cardiovascular function tests in multiple system atrophy. Fundam Clin Pharmacol. 1995;9:187\u201396. https:\/\/doi.org\/10.1111\/j.1472-8206.1995.tb00280.x.","DOI":"10.1111\/j.1472-8206.1995.tb00280.x"},{"key":"1453_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10286-015-0336-4","volume":"26","author":"A Fanciulli","year":"2016","unstructured":"Fanciulli A, Gobel G, Ndayisaba JP, Granata R, Duerr S, Strano S, Colosimo C, Poewe W, Pontieri FE, Wenning GK. Supine hypertension in Parkinson\u2019s disease and multiple system atrophy. Clin Auton Res. 2016;26:97\u2013105. https:\/\/doi.org\/10.1007\/s10286-015-0336-4.","journal-title":"Clin Auton Res"},{"key":"1453_CR46","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00415-014-7339-2","volume":"261","author":"A Fanciulli","year":"2014","unstructured":"Fanciulli A, Strano S, Ndayisaba JP, Goebel G, Gioffre L, Rizzo M, Colosimo C, Caltagirone C, Poewe W, Wenning GK, Pontieri FE. Detecting nocturnal hypertension in Parkinson\u2019s disease and multiple system atrophy: proposal of a decision-support algorithm. J Neurol. 2014;261:1291\u20139. https:\/\/doi.org\/10.1007\/s00415-014-7339-2.","journal-title":"J Neurol"},{"key":"1453_CR47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1468-1331.2012.03819.x","volume":"20","author":"A Fanciulli","year":"2013","unstructured":"Fanciulli A, Strano S, Colosimo C, Caltagirone C, Spalletta G, Pontieri FE. The potential prognostic role of cardiovascular autonomic failure in alpha-synucleinopathies. Eur J Neurol. 2013;20:231\u20135. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03819.x.","journal-title":"Eur J Neurol"},{"key":"1453_CR48","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1002\/mds.22767","volume":"24","author":"C Schmidt","year":"2009","unstructured":"Schmidt C, Berg D, Prieur S, Junghanns S, Schweitzer K, Globas C, Schols L, Reichmann H, Ziemssen T. Loss of nocturnal blood pressure fall in various extrapyramidal syndromes. Mov Disord. 2009;24:2136\u201342. https:\/\/doi.org\/10.1002\/mds.22767.","journal-title":"Mov Disord"},{"key":"1453_CR49","doi-asserted-by":"publisher","unstructured":"Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, Muller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan I, Stamelou M, Hoglinger GU and Movement Disorder Society-Endorsed PSPSG. Which ante mortem clinical features predict progressive supranuclear palsy pathology? Mov Disord 2017: 32:995\u20131005. https:\/\/doi.org\/10.1002\/mds.27034.","DOI":"10.1002\/mds.27034"},{"key":"1453_CR50","doi-asserted-by":"publisher","unstructured":"Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE and Quinn NP. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain. 1994;117(Pt 4):835\u201345. https:\/\/doi.org\/10.1093\/brain\/117.4.835.","DOI":"10.1093\/brain\/117.4.835"},{"key":"1453_CR51","doi-asserted-by":"publisher","unstructured":"Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S, Kollensperger M, Goebel G, Pfeiffer KP, Barone P, Pellecchia MT, Quinn NP, Koukouni V, Fowler CJ, Schrag A, Mathias CJ, Giladi N, Gurevich T, Dupont E, Ostergaard K, Nilsson CF, Widner H, Oertel W, Eggert KM, Albanese A, del Sorbo F, Tolosa E, Cardozo A, Deuschl G, Hellriegel H, Klockgether T, Dodel R, Sampaio C, Coelho M, Djaldetti R, Melamed E, Gasser T, Kamm C, Meco G, Colosimo C, Rascol O, Meissner WG, Tison F, Poewe W and European Multiple System Atrophy Study G. The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 2013;12:264\u201374. https:\/\/doi.org\/10.1016\/S1474-4422(12)70327-7.","DOI":"10.1016\/S1474-4422(12)70327-7"},{"key":"1453_CR52","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/S1474-4422(15)00058-7","volume":"14","author":"PA Low","year":"2015","unstructured":"Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, Tanner CM, Gilman S, Marshall FJ, Wooten F, Racette B, Chelimsky T, Singer W, Sletten DM, Sandroni P, Mandrekar J. Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol. 2015;14:710\u20139. https:\/\/doi.org\/10.1016\/S1474-4422(15)00058-7.","journal-title":"Lancet Neurol"},{"key":"1453_CR53","doi-asserted-by":"publisher","unstructured":"Stankovic I, Fanciulli A, Kostic VS, Krismer F, Meissner WG, Palma JA, Panicker JN, Seppi K, Wenning GK and MoDi MSASG. Laboratory-supported multiple system atrophy beyond autonomic function testing and imaging: a systematic review by the MoDiMSA Study Group. Mov Disord Clin Pract 2021;8:322\u201340. https:\/\/doi.org\/10.1002\/mdc3.13158.","DOI":"10.1002\/mdc3.13158"},{"key":"1453_CR54","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/jnnp.72.3.300","volume":"72","author":"SM Boesch","year":"2002","unstructured":"Boesch SM, Wenning GK, Ransmayr G, Poewe W. Dystonia in multiple system atrophy. J Neurol Neurosurg Psychiatry. 2002;72:300\u20133. https:\/\/doi.org\/10.1136\/jnnp.72.3.300.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1453_CR55","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/mds.27450","volume":"33","author":"A Batla","year":"2018","unstructured":"Batla A, De Pablo-Fernandez E, Erro R, Reich M, Calandra-Buonaura G, Barbosa P, Balint B, Ling H, Islam S, Cortelli P, Volkmann J, Quinn N, Holton JL, Warner TT, Bhatia KP. Young-onset multiple system atrophy: clinical and pathological features. Mov Disord. 2018;33:1099\u2013107. https:\/\/doi.org\/10.1002\/mds.27450.","journal-title":"Mov Disord"},{"key":"1453_CR56","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/mds.21999","volume":"23","author":"T Anderson","year":"2008","unstructured":"Anderson T, Luxon L, Quinn N, Daniel S, Marsden CD, Bronstein A. Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients. Mov Disord. 2008;23:977\u201384. https:\/\/doi.org\/10.1002\/mds.21999.","journal-title":"Mov Disord"},{"key":"1453_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-10994-3","author":"V Schneider","year":"2022","unstructured":"Schneider V, Wirth T, Iosif A, Montaut S, Lagha-Boukbiza O, Tranchant C, Anheim M. \u201cPhalanx sign\u201d helps to discriminate MSA-C from idiopathic late onset cerebellar ataxia. J Neurol. 2022. https:\/\/doi.org\/10.1007\/s00415-022-10994-3.","journal-title":"J Neurol"},{"key":"1453_CR58","doi-asserted-by":"publisher","unstructured":"Trojanowski JQ, Revesz T and Neuropathology Working Group on MSA 2007 Proposed neuropathological criteria for the postmortem diagnosis of multiple system atrophy Neuropathol Appl Neurobiol. 33 615 20 https:\/\/doi.org\/10.1111\/j.1365-2990.2007.00907.x.","DOI":"10.1111\/j.1365-2990.2007.00907.x"},{"key":"1453_CR59","doi-asserted-by":"publisher","unstructured":"Kollensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, Boesch S, Mueller J, Koukouni V, Quinn N, Pellecchia MT, Barone P, Schimke N, Dodel R, Oertel W, Dupont E, Ostergaard K, Daniels C, Deuschl G, Gurevich T, Giladi N, Coelho M, Sampaio C, Nilsson C, Widner H, Sorbo FD, Albanese A, Cardozo A, Tolosa E, Abele M, Klockgether T, Kamm C, Gasser T, Djaldetti R, Colosimo C, Meco G, Schrag A, Poewe W, Wenning GK and European MSASG. Red flags for multiple system atrophy. Mov Disord 2008;23:1093\u20139. https:\/\/doi.org\/10.1002\/mds.21992","DOI":"10.1002\/mds.21992"},{"key":"1453_CR60","doi-asserted-by":"publisher","unstructured":"Pellecchia MT, Stankovic I, Fanciulli A, Krismer F, Meissner WG, Palma JA, Panicker JN, Seppi K, Wenning GK and Members of the Movement Disorder Society Multiple System Atrophy Study G. Can autonomic testing and imaging contribute to the early diagnosis of multiple system atrophy? A systematic review and recommendations by the Movement Disorder Society Multiple System Atrophy Study Group. Mov Disord Clin Pract 2020;7:750\u201362. https:\/\/doi.org\/10.1002\/mdc3.13052.","DOI":"10.1002\/mdc3.13052"},{"key":"1453_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-022-00853-6","author":"C Eckhardt","year":"2022","unstructured":"Eckhardt C, Krismer F, Donnemiller E, Eschlbock S, Fanciulli A, Raccagni C, Bosch S, Mair K, Scherfler C, Djamshidian A, Uprimny C, Metzler B, Seppi K, Poewe W, Kiechl S, Virgolini I, Wenning GK. Cardiac sympathetic innervation in Parkinson\u2019s disease versus multiple system atrophy. Clin Auton Res. 2022. https:\/\/doi.org\/10.1007\/s10286-022-00853-6.","journal-title":"Clin Auton Res"},{"key":"1453_CR62","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager J, Andersen KB, Knudsen K, Skjaerbaek C, Fedorova TD, Okkels N, Schaeffer E, Bonkat SK, Geday J, Otto M, Sommerauer M, Danielsen EH, Bech E, Kraft J, Munk OL, Hansen SD, Pavese N, Goder R, Brooks DJ, Berg D, Borghammer P. Brain-first versus body-first Parkinson\u2019s disease: a multimodal imaging case-control study. Brain. 2020;143:3077\u201388. https:\/\/doi.org\/10.1093\/brain\/awaa238.","journal-title":"Brain"},{"key":"1453_CR63","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/ana.26089","volume":"89","author":"W Singer","year":"2021","unstructured":"Singer W, Schmeichel AM, Shahnawaz M, Schmelzer JD, Sletten DM, Gehrking TL, Gehrking JA, Olson AD, Suarez MD, Misra PP, Soto C, Low PA. Alpha-synuclein oligomers and neurofilament light chain predict phenoconversion of pure autonomic failure. Ann Neurol. 2021;89:1212\u201320. https:\/\/doi.org\/10.1002\/ana.26089.","journal-title":"Ann Neurol"},{"key":"1453_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25824","author":"W Singer","year":"2020","unstructured":"Singer W, Schmeichel AM, Shahnawaz M, Schmelzer JD, Boeve BF, Sletten DM, Gehrking TL, Gehrking JA, Olson AD, Savica R, Suarez MD, Soto C, Low PA. Alpha-synuclein oligomers and neurofilament light chain in spinal fluid differentiate multiple system atrophy from Lewy body synucleinopathies. Ann Neurol. 2020. https:\/\/doi.org\/10.1002\/ana.25824.","journal-title":"Ann Neurol"},{"key":"1453_CR65","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/mds.1121","volume":"16","author":"DB Vodusek","year":"2001","unstructured":"Vodusek DB. Sphincter EMG and differential diagnosis of multiple system atrophy. Mov Disord. 2001;16:600\u20137. https:\/\/doi.org\/10.1002\/mds.1121.","journal-title":"Mov Disord"},{"key":"1453_CR66","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/mds.20584","volume":"20","author":"DC Paviour","year":"2005","unstructured":"Paviour DC, Williams D, Fowler CJ, Quinn NP, Lees AJ. Is sphincter electromyography a helpful investigation in the diagnosis of multiple system atrophy? A retrospective study with pathological diagnosis. Mov Disord. 2005;20:1425\u201330. https:\/\/doi.org\/10.1002\/mds.20584.","journal-title":"Mov Disord"},{"key":"1453_CR67","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/mds.27635","volume":"34","author":"A Fanciulli","year":"2019","unstructured":"Fanciulli A, Goebel G, Lazzeri G, Scherfler C, Gizewski ER, Granata R, Kiss G, Strano S, Colosimo C, Pontieri FE, Kaufmann H, Seppi K, Poewe W, Wenning GK. Early distinction of Parkinson-variant multiple system atrophy from Parkinson\u2019s disease. Mov Disord. 2019;34:440\u20131. https:\/\/doi.org\/10.1002\/mds.27635.","journal-title":"Mov Disord"},{"key":"1453_CR68","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10286-018-0504-4","volume":"28","author":"E Indelicato","year":"2018","unstructured":"Indelicato E, Fanciulli A, Ndayisaba JP, Nachbauer W, Granata R, Wanschitz J, Wagner M, Gizewski ER, Poewe W, Wenning GK, Boesch S. Autonomic function testing in spinocerebellar ataxia type 2. Clin Auton Res. 2018;28:341\u20136. https:\/\/doi.org\/10.1007\/s10286-018-0504-4.","journal-title":"Clin Auton Res"},{"key":"1453_CR69","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00415-019-09684-4","volume":"267","author":"E Indelicato","year":"2020","unstructured":"Indelicato E, Fanciulli A, Nachbauer W, Eigentler A, Amprosi M, Ndayisaba JP, Granata R, Wenning G, Boesch S. Cardiovascular autonomic testing in the work-up of cerebellar ataxia: insight from an observational single center study. J Neurol. 2020;267:1097\u2013102. https:\/\/doi.org\/10.1007\/s00415-019-09684-4.","journal-title":"J Neurol"},{"key":"1453_CR70","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU Hoglinger","year":"2017","unstructured":"Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Muller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. 2017;32:853\u201364. https:\/\/doi.org\/10.1002\/mds.26987.","journal-title":"Mov Disord"},{"key":"1453_CR71","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, Riley DE, Tolosa E, Troster AI, Vidailhet M, Weiner WJ. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80:496\u2013503. https:\/\/doi.org\/10.1212\/WNL.0b013e31827f0fd1.","journal-title":"Neurology"},{"key":"1453_CR72","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10072-021-05746-6","volume":"43","author":"F Leys","year":"2022","unstructured":"Leys F, Wenning GK, Fanciulli A. The role of cardiovascular autonomic failure in the differential diagnosis of alpha-synucleinopathies. Neurol Sci. 2022;43:187\u201398. https:\/\/doi.org\/10.1007\/s10072-021-05746-6.","journal-title":"Neurol Sci"},{"key":"1453_CR73","doi-asserted-by":"publisher","first-page":"e1339","DOI":"10.1212\/WNL.0000000000008197","volume":"93","author":"JA van Gerpen","year":"2019","unstructured":"van Gerpen JA, Al-Shaikh RH, Tipton PW, Wszolek ZK, Uitti RJ, Ferman TJ, Dickson DW, Benarroch EE, Singer W, Cutsforth-Gregory JK, Heckman MG, Brushaber DE, Josephs KA, Low PA, Ahlskog JE, Cheshire WP. Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension. Neurology. 2019;93:e1339\u201347. https:\/\/doi.org\/10.1212\/WNL.0000000000008197.","journal-title":"Neurology"},{"key":"1453_CR74","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1002\/nau.23496","volume":"37","author":"KJ Kim","year":"2018","unstructured":"Kim KJ, Jeong SJ, Kim JM. Neurogenic bladder in progressive supranuclear palsy: a comparison with Parkinson\u2019s disease and multiple system atrophy. Neurourol Urodyn. 2018;37:1724\u201330. https:\/\/doi.org\/10.1002\/nau.23496.","journal-title":"Neurourol Urodyn"},{"key":"1453_CR75","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/S0022-5347(17)35246-1","volume":"151","author":"RO Beck","year":"1994","unstructured":"Beck RO, Betts CD, Fowler CJ. Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases. J Urol. 1994;151:1336\u201341. https:\/\/doi.org\/10.1016\/s0022-5347(17)35246-1.","journal-title":"J Urol"},{"key":"1453_CR76","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1046\/j.1464-410X.1997.00249.x","volume":"80","author":"VA Chandiramani","year":"1997","unstructured":"Chandiramani VA, Palace J, Fowler CJ. How to recognize patients with parkinsonism who should not have urological surgery. Br J Urol. 1997;80:100\u20134. https:\/\/doi.org\/10.1046\/j.1464-410x.1997.00249.x.","journal-title":"Br J Urol"},{"key":"1453_CR77","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/jnnp.68.4.434","volume":"68","author":"GK Wenning","year":"2000","unstructured":"Wenning GK, Ben-Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson\u2019s disease? J Neurol Neurosurg Psychiatry. 2000;68:434\u201340. https:\/\/doi.org\/10.1136\/jnnp.68.4.434.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1453_CR78","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1001\/archneur.1995.00540270090024","volume":"52","author":"C Colosimo","year":"1995","unstructured":"Colosimo C, Albanese A, Hughes AJ, de Bruin VM, Lees AJ. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson\u2019s disease. Arch Neurol. 1995;52:294\u20138. https:\/\/doi.org\/10.1001\/archneur.1995.00540270090024.","journal-title":"Arch Neurol"},{"key":"1453_CR79","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/mds.870100310","volume":"10","author":"N Gouider-Khouja","year":"1995","unstructured":"Gouider-Khouja N, Vidailhet M, Bonnet AM, Pichon J, Agid Y. \u201cPure\u201d striatonigral degeneration and Parkinson\u2019s disease: a comparative clinical study. Mov Disord. 1995;10:288\u201394. https:\/\/doi.org\/10.1002\/mds.870100310.","journal-title":"Mov Disord"},{"key":"1453_CR80","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/1531-8257(199911)14:6<947::AID-MDS1006>3.0.CO;2-O","volume":"14","author":"GK Wenning","year":"1999","unstructured":"Wenning GK, Ebersbach G, Verny M, Chaudhuri KR, Jellinger K, McKee A, Poewe W, Litvan I. Progression of falls in postmortem-confirmed parkinsonian disorders. Mov Disord. 1999;14:947\u201350. https:\/\/doi.org\/10.1002\/1531-8257(199911)14:63.0.co;2-o.","journal-title":"Mov Disord"},{"key":"1453_CR81","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1007\/s00415-019-09271-7","volume":"266","author":"J Rusz","year":"2019","unstructured":"Rusz J, Tykalova T, Salerno G, Bancone S, Scarpelli J, Pellecchia MT. Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy. J Neurol. 2019;266:1394\u2013404. https:\/\/doi.org\/10.1007\/s00415-019-09271-7.","journal-title":"J Neurol"},{"key":"1453_CR82","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30:1591\u2013601. https:\/\/doi.org\/10.1002\/mds.26424.","journal-title":"Mov Disord"},{"key":"1453_CR83","doi-asserted-by":"publisher","unstructured":"Stankovic I, Krismer F, Jesic A, Antonini A, Benke T, Brown RG, Burn DJ, Holton JL, Kaufmann H, Kostic VS, Ling H, Meissner WG, Poewe W, Semnic M, Seppi K, Takeda A, Weintraub D, Wenning GK and Movement Disorders Society MSASG. Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group. Mov Disord 2014: 29:857\u201367. https:\/\/doi.org\/10.1002\/mds.25880.","DOI":"10.1002\/mds.25880"},{"key":"1453_CR84","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1474-4422(05)70146-0","volume":"4","author":"DR Williams","year":"2005","unstructured":"Williams DR, Lees AJ. Visual hallucinations in the diagnosis of idiopathic Parkinson\u2019s disease: a retrospective autopsy study. Lancet Neurol. 2005;4:605\u201310. https:\/\/doi.org\/10.1016\/S1474-4422(05)70146-0.","journal-title":"Lancet Neurol"},{"key":"1453_CR85","doi-asserted-by":"publisher","unstructured":"Meissner WG, Laurencin C, Tranchant C, Witjas T, Viallet F, Guehl D, Damier P, Houeto JL, Tison F, Eusebio A, Vital A, Streichenberger N, Lannes B, Maues de Paula A and Thobois S. Outcome of deep brain stimulation in slowly progressive multiple system atrophy: a clinico-pathological series and review of the literature. Parkinsonism Relat Disord 2016;24:69\u201375. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.01.005.","DOI":"10.1016\/j.parkreldis.2016.01.005"},{"key":"1453_CR86","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/mds.25115","volume":"27","author":"IN Petrovic","year":"2012","unstructured":"Petrovic IN, Ling H, Asi Y, Ahmed Z, Kukkle PL, Hazrati LN, Lang AE, Revesz T, Holton JL, Lees AJ. Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord. 2012;27:1186\u201390. https:\/\/doi.org\/10.1002\/mds.25115.","journal-title":"Mov Disord"},{"key":"1453_CR87","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1001\/archneur.1997.00550200007003","volume":"54","author":"I Litvan","year":"1997","unstructured":"Litvan I, Goetz CG, Jankovic J, Wenning GK, Booth V, Bartko JJ, McKee A, Jellinger K, Lai EC, Brandel JP, Verny M, Chaudhuri KR, Pearce RK, Agid Y. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study Arch Neurol. 1997;54:937\u201344. https:\/\/doi.org\/10.1001\/archneur.1997.00550200007003.","journal-title":"A clinicopathologic study Arch Neurol"},{"key":"1453_CR88","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/jnnp.58.2.160","volume":"58","author":"GK Wenning","year":"1995","unstructured":"Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry. 1995;58:160\u20136. https:\/\/doi.org\/10.1136\/jnnp.58.2.160.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1453_CR89","doi-asserted-by":"publisher","unstructured":"Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Muller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I and Movement Disorder Society-endorsed PSPSG. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 2017: 32:853\u201364. https:\/\/doi.org\/10.1002\/mds.26987","DOI":"10.1002\/mds.26987"},{"key":"1453_CR90","doi-asserted-by":"publisher","unstructured":"Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN and Group NS 2009 Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study Brain 132 156 171.\u00a0https:\/\/doi.org\/10.1093\/brain\/awn291.","DOI":"10.1093\/brain\/awn291"},{"key":"1453_CR91","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O\u2019Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89:88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058.","journal-title":"Neurology"},{"key":"1453_CR92","doi-asserted-by":"publisher","unstructured":"Kao AW, Racine CA, Quitania LC, Kramer JH, Christine CW, Miller BL. Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy. Alzheimer Dis Assoc Disord. 2009;23:365\u201370. https:\/\/doi.org\/10.1097\/WAD.0b013e3181b5065d.","DOI":"10.1097\/WAD.0b013e3181b5065d"},{"key":"1453_CR93","doi-asserted-by":"publisher","unstructured":"Giordano I, Harmuth F, Jacobi H, Paap B, Vielhaber S, Machts J, Schols L, Synofzik M, Sturm M, Tallaksen C, Wedding IM, Boesch S, Eigentler A, van de Warrenburg B, van Gaalen J, Kamm C, Dudesek A, Kang JS, Timmann D, Silvestri G, Masciullo M, Klopstock T, Neuhofer C, Ganos C, Filla A, Bauer P, Tezenas du Montcel S and Klockgether T. Clinical and genetic characteristics of sporadic adult-onset degenerative ataxia. Neurology 2017: 89:1043\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000004311","DOI":"10.1212\/WNL.0000000000004311"},{"key":"1453_CR94","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/B978-0-444-64189-2.00014-7","volume":"155","author":"T Klockgether","year":"2018","unstructured":"Klockgether T. Sporadic adult-onset ataxia. Handb Clin Neurol. 2018;155:217\u201325. https:\/\/doi.org\/10.1016\/B978-0-444-64189-2.00014-7.","journal-title":"Handb Clin Neurol"},{"key":"1453_CR95","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1017\/s0317167100013834","volume":"40","author":"A Lloyd-Smith","year":"2013","unstructured":"Lloyd-Smith A, Jacova P, Schulzer M, Spacey SD. Early clinical features differentiate cerebellar variant MSA and sporadic ataxia. Can J Neurol Sci. 2013;40:252\u20134. https:\/\/doi.org\/10.1017\/s0317167100013834.","journal-title":"Can J Neurol Sci"},{"key":"1453_CR96","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s12311-015-0728-y","volume":"15","author":"DJ Lin","year":"2016","unstructured":"Lin DJ, Hermann KL, Schmahmann JD. The diagnosis and natural history of multiple system atrophy, cerebellar type. Cerebellum. 2016;15:663\u201379. https:\/\/doi.org\/10.1007\/s12311-015-0728-y.","journal-title":"Cerebellum"},{"key":"1453_CR97","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s00415-021-10763-8","volume":"269","author":"N Dragasevic-Miskovic","year":"2022","unstructured":"Dragasevic-Miskovic N, Stankovic I, Milovanovic A, Kostic VS. Autosomal recessive adult onset ataxia. J Neurol. 2022;269:504\u201333. https:\/\/doi.org\/10.1007\/s00415-021-10763-8.","journal-title":"J Neurol"},{"key":"1453_CR98","doi-asserted-by":"publisher","unstructured":"Multiple-System Atrophy Research C. Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med 2013: 369:233\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1212115.","DOI":"10.1056\/NEJMoa1212115"},{"key":"1453_CR99","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s12311-020-01132-8","volume":"19","author":"M Hadjivassiliou","year":"2020","unstructured":"Hadjivassiliou M, Graus F, Honnorat J, Jarius S, Titulaer M, Manto M, Hoggard N, Sarrigiannis P, Mitoma H. Diagnostic criteria for primary autoimmune cerebellar ataxia-guidelines from an International Task Force on immune-mediated cerebellar ataxias. Cerebellum. 2020;19:605\u201310. https:\/\/doi.org\/10.1007\/s12311-020-01132-8.","journal-title":"Cerebellum"},{"key":"1453_CR100","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/mdc3.13404","volume":"9","author":"E Mulroy","year":"2022","unstructured":"Mulroy E, Balint B, Bhatia KP. Homer-3 antibody disease: a potentially treatable MSA-C mimic. Mov Disord Clin Pract. 2022;9:178\u201382. https:\/\/doi.org\/10.1002\/mdc3.13404.","journal-title":"Mov Disord Clin Pract"},{"key":"1453_CR101","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G. MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord. 2015;30:1600\u201311. https:\/\/doi.org\/10.1002\/mds.26431.","journal-title":"Mov Disord"},{"key":"1453_CR102","doi-asserted-by":"publisher","unstructured":"McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, Kantarci K, Muscio C, O'Brien JT, Postuma RB, Aarsland D, Ballard C, Bonanni L, Donaghy P, Emre M, Galvin JE, Galasko D, Goldman JG, Gomperts SN, Honig LS, Ikeda M, Leverenz JB, Lewis SJG, Marder KS, Masellis M, Salmon DP, Taylor JP, Tsuang DW, Walker Z, Tiraboschi P and prodromal DLBDSG. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology 2020: 94:743\u201355. https:\/\/doi.org\/10.1212\/WNL.0000000000009323","DOI":"10.1212\/WNL.0000000000009323"},{"key":"1453_CR103","doi-asserted-by":"publisher","unstructured":"Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB and Disease MDSTFotDoPs. Update of the MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord 2019: 34:1464\u201370. https:\/\/doi.org\/10.1002\/mds.27802.","DOI":"10.1002\/mds.27802"},{"key":"1453_CR104","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ana.24877","volume":"81","author":"H Kaufmann","year":"2017","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, Low PA, Singer W, Goldstein DS, Peltier AC, Shibao CA, Gibbons CH, Freeman R, Robertson D, Autonomic DC. Natural history of pure autonomic failure: a United States prospective cohort. Ann Neurol. 2017;81:287\u201397. https:\/\/doi.org\/10.1002\/ana.24877.","journal-title":"Ann Neurol"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-022-01453-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-022-01453-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-022-01453-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T04:34:46Z","timestamp":1694061286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-022-01453-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":104,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["1453"],"URL":"https:\/\/doi.org\/10.1007\/s12311-022-01453-w","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"assertion":[{"value":"30 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Full financial disclosures for the past 12\u00a0months:Iva Stankovic: Dr. Stankovic has nothing to disclose.Alessandra Fanciulli: Dr. Fanciulli reports royalties from Springer Nature Publishing Group, speaker fees and honoraria from International Parkinson Disease and Movement Disorders Society, Austrian Neurology Society, Austrian Autonomic Society, Abbvie, and Theravance Biopharma, and research grants from the Stichting ParkinsonFond, US MSA Coalition, Dr. Johannes Tuba Stiftung and the \u00d6sterreichischer Austausch Dienst, outside of the submitted work.Victoria Sidoroff: Dr. Sidoroff has nothing to disclose.Gregor K. Wenning: Dr. Wenning reports speaker honoraria from Biohaven, Biogen, Inhibikase, Lundbeck, Ono, Takeda, and Theravance.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}